Stay updated on Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now displays the clinical trial record for the ipilimumab, nivolumab, and radiation therapy study, including study details, eligibility criteria, outcomes, and posted results. It also provides links to the study protocol and informed consent form.SummaryDifference63%

- Check18 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedA notice banner announces the NIH website transition and says that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check31 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check38 days agoChange DetectedThe footer revision identifier was updated from v3.7.0 to v3.7.1 on the error page.SummaryDifference0.2%

- Check59 days agoChange DetectedThe page now shows a 403 Forbidden error for the study record, signaling access restrictions, while much of the surrounding institutional content and documents are removed, leaving an error screen instead of the usual study details.SummaryDifference21%

Stay in the know with updates to Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page.